SMS Lifesciences Complete Financial Statements
SMSLIFE • Review detailed financials to uncover trends, confirm thesis & journal trades
8 Years of Data
2025 - 2018
Complete Financial Data Export
Export complete financial statements for SMS Lifesciences (SMSLIFE).
Downloads include all available records across all periods.
For market performance, see the
SMSLIFE stock price today
.
Profitability Ratios
Net Profit Margin
4.35%
2025 data
EBITDA Margin
10.87%
2025 data
Operating Margin
8.00%
2025 data
Return on Assets
1.03%
2025 data
Return on Equity
1.89%
2025 data
Balance Sheet Ratios
Current Ratio
4.19
2025 data
Debt to Equity
1.84
2025 data
Equity Ratio
54.36%
2025 data
Asset Turnover
0.24
2025 data
Year-over-Year Growth Analysis
Comparing Mar 2024 vs Mar 2025
Net Profit Growth
-42.9%
Year-over-Year
EBITDA Growth
-28.6%
Year-over-Year
Expense Growth
+3.8%
Year-over-Year
Assets Growth
-0.3%
Year-over-Year
Equity Growth
+9.3%
Year-over-Year
Liabilities Growth
-0.3%
Year-over-Year
Operating Cash Flow Growth
+41.7%
Year-over-Year
Investing Cash Flow Growth
+21.1%
Year-over-Year
Financing Cash Flow Growth
-171.4%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Jun 2018 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 92 | 84 | 81 | 92 | 93 | 85 | 70 | 69 | 75 | 73 | 81 | 102 | 83 | 89 | 95 | 84 | 76 | 91 | 62 | 47 | 55 | 67 | 77 | 109 | 92 | 47 | 92 | 76 | 103 |
| Expenses | 82 | 71 | 70 | 79 | 76 | 72 | 61 | 62 | 72 | 63 | 73 | 89 | 74 | 79 | 77 | 74 | 68 | 83 | 54 | 42 | 48 | 60 | 68 | 100 | 82 | 44 | 82 | 71 | 91 |
| EBITDA | 10 | 13 | 11 | 14 | 17 | 13 | 8 | 7 | 3 | 10 | 8 | 13 | 9 | 10 | 18 | 10 | 8 | 9 | 8 | 5 | 7 | 7 | 9 | 9 | 10 | 3 | 10 | 5 | 13 |
| Operating Profit Margin % | 8.00% | 14.00% | 11.00% | 13.00% | 18.00% | 15.00% | 11.00% | 4.00% | 3.00% | 13.00% | 10.00% | 7.00% | 10.00% | 11.00% | 11.00% | 10.00% | 11.00% | 9.00% | 13.00% | 8.00% | 12.00% | 10.00% | 11.00% | 7.00% | 11.00% | 6.00% | 11.00% | 6.00% | 12.00% |
| Depreciation | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 |
| Interest | 2 | 2 | 2 | 3 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Profit Before Tax | 4 | 7 | 5 | 7 | 11 | 7 | 2 | 2 | -3 | 4 | 4 | 9 | 5 | 6 | 14 | 7 | 5 | 4 | 5 | 1 | 4 | 4 | 6 | 6 | 7 | 0 | 7 | 4 | 9 |
| Tax | 1 | 3 | 1 | 1 | 4 | 2 | 2 | 0 | 1 | 0 | 1 | 1 | 2 | 2 | 3 | 2 | 1 | 2 | 2 | 0 | 1 | 2 | 2 | 1 | 2 | 0 | 2 | 1 | 3 |
| Net Profit | 4 | 4 | 3 | 7 | 7 | 5 | 0 | 2 | -4 | 4 | 3 | 8 | 2 | 4 | 10 | 5 | 4 | 2 | 3 | 2 | 3 | 3 | 4 | 5 | 5 | 0 | 5 | 3 | 6 |
| Earnings Per Share (₹) | 9.83 | 13.75 | 15.46 | 19.53 | 23.15 | 18.08 | 2.20 | 5.66 | -5.94 | 14.24 | 9.10 | 26.00 | 9.95 | 13.18 | 33.91 | 16.72 | 12.00 | 7.70 | 10.96 | 5.20 | 8.21 | 8.92 | 12.18 | 15.22 | 15.61 | -1.12 | 15.60 | 9.51 | 18.77 |
Related Pages for SMS Lifesciences
Additional stock information and data for SMSLIFE
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Total Assets | 390 | 391 | 395 | 357 | 302 | 253 | 270 |
| Current Assets | 151 | 156 | 159 | 156 | 126 | 107 | 142 |
| Fixed Assets | 232 | 223 | 228 | 142 | 130 | 124 | 119 |
| Capital Work in Progress | 0 | 6 | 1 | 51 | 38 | 16 | 3 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 158 | 162 | 166 | 164 | 134 | 113 | 148 |
| LIABILITIES | |||||||
| Total Liabilities | 390 | 391 | 395 | 357 | 302 | 253 | 270 |
| Current Liabilities | 36 | 52 | 73 | 56 | 59 | 50 | 39 |
| Non-Current Liabilities | |||||||
| SHAREHOLDERS' EQUITY | |||||||
| Total Equity | 212 | 194 | 188 | 165 | 129 | 116 | 106 |
| Share Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves & Surplus | 194 | 174 | 166 | 149 | 126 | 113 | 103 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | 34 | 24 | 15 | -11 | 35 | 15 | 30 |
| Investing Activities | -15 | -19 | -31 | -7 | -26 | -27 | -44 |
| Financing Activities | -19 | -7 | 17 | 11 | -3 | 12 | 15 |
| Net Cash Flow | 0 | -1 | 0 | -8 | 6 | 0 | 1 |